Nucleome Therapeutics appoints Nigel Clark as Chief Business Officer Nigel brings 20+ years of commercial and senior managerial experience in the biotech and pharma industry Oxford, UK
Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics Study conducted by Nucleome's academic founders at the University
Investegate announcements from Nucleome Therapeutics, Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics
Ultromics Raises $33M in Series B Funding finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.